United States · Investor

Pittsburgh Life Sciences Greenho

Last cheque observed Jun 2014. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietAccelerator

Pre-seedSeedSeries ACyber SecurityPoint Of SaleBiotechnology

Cheques on record
0%of best year0cheques in 12 months, 34 on record
Since the last cheque4518days00hrs00min00sec
Median round$200KRounds led0 of 34Sole investor18 roundsMostly inUnited States, 100%
Pitch Pittsburgh Life Sciences Greenho

Pittsburgh Life Sciences Greenho highlights

  1. 01

    34 rounds on record

  2. 02

    Mostly Venture and Series A: 79% of its rounds

  3. 03

    Sole investor in 18 rounds, median $120K

What they do

Type
Accelerator (from a list, unverified)
Cheque size
Not stated
Stages
Pre-seedSeedSeries ASeries BGrowthPre-IPO
Sectors
Cyber SecurityPoint Of SaleBiotechnology
Based in
Pittsburgh, United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first34 appearances

  1. 2014

    1 round

  2. Jun
    Carmell TherapeuticsSeries A · US$1.0MWith 3 others
  3. 2013

    4 rounds

  4. Dec
    CernosticsSeries B · US · finsmes.com$1.4MWith 2 others
  5. Oct
    ComplexaSeed · US · finsmes.com$200KWith 1 other
  6. Oct
    Cognition TherapeuticsSeed · US · finsmes.com$138KWith 1 other
  7. Sept
    ALung TechnologiesSeries B · US · finsmes.com$16MWith 8 others
  8. 2012

    1 round

  9. Jun
    Quantum OPSSeries A · US · finsmes.com$1.1MWith 2 others
  10. 2011

    2 rounds

  11. Apr
    Carmell TherapeuticsSeries A · US · bizjournals.com$2.4MWith 5 others
  12. Jan
    Cognition TherapeuticsSeries A · US · finsmes.com$2.5MWith 5 others
  13. 2010

    2 rounds

  14. Nov
    Intimate Bridge 2 ConceptionVenture · US · finsmes.com$475KWith 1 other
  15. Mar
    Saladax BiomedicalSeries C · US · onbiovc.com$8.4MWith 4 others
  16. 2009

    4 rounds

  17. Dec
    ThermalTherapeuticSystemsSeries A · US · onbiovc.com$2.7MWith 2 others
  18. Sept
    CardioroboticsSeries A · US · onbiovc.com$12MWith 2 others
  19. Jul
    Cognition TherapeuticsSeries A · US · cogrx.com$1.2MWith 3 others
  20. Feb
    Caliber InfosolutionsUS · pittsburghlifesciences.infoUndisclosedSole investor
  21. 2008

    2 rounds

  22. Apr
    Lipella PharmaceuticalsVenture · US$240KSole investor
  23. Jan
    Carmell TherapeuticsVenture · US$130KSole investor
  24. 2007

    7 rounds

  25. Dec
    ParentPlusVenture · plsg.com$100KSole investor
  26. Nov
    Cognition TherapeuticsSeed · US · cogrx.com$200KSole investor
  27. Nov
    CrystalplexVenture · US$150KSole investor
  28. Nov
    Applied Isotope TechnologiesVenture · US · plsg.com$150KSole investor
  29. May
    ChemDAQVenture · US · bizjournals.com$120KSole investor
  30. May
    CelsenseVenture · US · plsg.com$150KSole investor
  31. Apr
    StageMarkSeries B · US · allbusiness.com$1.6MWith 6 others
  32. 2006

    10 rounds

  33. Dec
    STARR Life SciencesVenture · US · sec.gov$1.4MSole investor
  34. Dec
    Lipella PharmaceuticalsVenture · US$120KSole investor
  35. Oct
    Applied Computational TechnologiesVenture · US · appcomptech.com$200KWith 1 other
  36. Oct
    ProteopureVenture · US$50KSole investor
  37. Oct
    ProteopureVenture · US$40KSole investor
  38. Apr
    ImmunetricsVenture · US$150KSole investor
  39. Mar
    Applied Isotope TechnologiesVenture · US · plsg.com$100KSole investor
  40. Mar
    ProteopureVenture · US · plsg.com$100KSole investor
  41. Mar
    StageMarkVenture · US$210KWith 1 other
  42. Feb
    StageMarkVenture · US$90KSole investor
  43. 2005

    1 round

  44. Sept
    ProteopureVenture · US$100KSole investor

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 8 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Who they invest alongside

The investors most often in the same rounds as Pittsburgh Life Sciences Greenho. A count of rooms they were both in, not a relationship either has claimed.

Innovation WorksGovernment8rounds togetherAccelerator FundVC firm4rounds togetherBlueTree Allied AngelsAngel network4rounds togetherBen Franklin Technology PartnersGovernment2rounds togetherEagle VenturesVC firm2rounds togetherGolden SeedsAngel network2rounds togetherHarbor Light Capital PartnersVC firm2rounds togetherM5Invest PartnersVC firm2rounds togetherOgden CapitalVC firm2rounds together

Quick answers about Pittsburgh Life Sciences Greenho

What does Pittsburgh Life Sciences Greenho invest in?

Pittsburgh Life Sciences Greenho invests most often at Venture and Series A (79% of the rounds on record), in sectors such as Cyber Security, Point Of Sale and Biotechnology.

How active is Pittsburgh Life Sciences Greenho?

34 investments on record, 0 of them in the last 12 months. The most recent was in Jun 2014.

How big are Pittsburgh Life Sciences Greenho's cheques?

The median round it joins is $200K.

Does Pittsburgh Life Sciences Greenho lead rounds?

Rarely, if at all: none of its 34 investments on record names it as the lead.

Where does Pittsburgh Life Sciences Greenho invest?

Most of the companies it backs are in the United States (100%).

Is Pittsburgh Life Sciences Greenho investing now?

No investments in the last 12 months; the latest was in Jun 2014.

Who does Pittsburgh Life Sciences Greenho invest alongside?

Most often Innovation Works (8 rounds together), Accelerator Fund (4 rounds together) and BlueTree Allied Angels (4 rounds together).

What kind of investor is Pittsburgh Life Sciences Greenho?

Pittsburgh Life Sciences Greenho is an accelerator based in Pittsburgh, United States.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it